S.1632 - Strategic Drug Intelligence Act of 1989101st Congress (1989-1990)
|Sponsor:||Sen. Roth Jr., William V. [R-DE] (Introduced 09/15/1989)|
|Committees:||Senate - Governmental Affairs|
|Latest Action:||Senate - 09/15/1989 Read twice and referred to the Committee on Governmental Affairs. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Text: S.1632 — 101st Congress (1989-1990)All Information (Except Text)
There is one version of the bill.
Text available as:
- This text predates authenticated digital publishing. It may be incomplete.
Introduced in Senate
S 1632 IS 101st CONGRESS 1st Session S. 1632 To establish a Federal Strategic Drug Intelligence Center. IN THE SENATE OF THE UNITED STATES September 15 (legislative day, SEPTEMBER 6), 1989 Mr. ROTH introduced the following bill; which was read twice and referred to the Committee on Governmental Affairs A BILL To establish a Federal Strategic Drug Intelligence Center. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the `Strategic Drug Intelligence Act of 1989'. SEC. 2. FINDINGS. The Congress finds that-- (1) much of the relevant information the Federal Government possesses related to foreign and domestic drug trafficking organizations is in manual files which cannot be used easily, quickly, or completely; (2) each Federal agency maintains its own files which, by their nature, are difficult to share with other agencies; (3) no Federal agency has ready access to all the data needed to produce a comprehensive understanding of the international and domestic trafficking organizations; and (4) there is no centralized data base of information which can be fully utilized by responsible Federal agencies. SEC. 3. ESTABLISHMENT AND RESPONSIBILITIES OF CENTER. (a) ESTABLISHMENT OF THE CENTER- There is established an executive agency to be known as the `Strategic Drug Intelligence Center' (referred to as the `Center'). (b) RESPONSIBILITIES OF THE CENTER- The Center shall-- (1) assimilate the collective information, data, intelligence, and analytical capabilities of National Drug Control Program agencies; (2) produce the most comprehensive possible analysis of the foreign and domestic drug trafficking organizations and their operations; (3) create and maintain a state-of-the-art computer data base for drug-related strategic intelligence; and (4) disseminate comprehensive intelligence on drug organizations to appropriate intelligence and enforcement agencies. (c) DATE OF OPERATION- The Center shall begin operations not later than 90 days after the Director of the Office of Drug Center Policy submits the plan referred to in section 5. SEC. 4. MANAGEMENT OF CENTER. (a) ESTABLISHMENT OF BOARD- There shall be at the head of the Center a board known as the `Strategic Drug Intelligence Board' (referred to as the `Board') which shall be responsible for the management of the Center. The Director of the Office of Drug Control Policy shall be the chairman of the Board. The heads of the other Federal agencies participating in the Center shall be members of the Board. (b) RESPONSIBILITIES OF THE BOARD- The Board shall-- (1) allocate the Center's funding; (2) determine the Center's priorities; (3) select an executive agent for the Center from among the Board members who shall designate senior managers for the Center, subject to Board approval; (4) design a format for information to be collected giving due regard to the sensitivity of certain information; and (5) adopt procedures governing access to information contained in the data bases. SEC. 5. PLAN FOR CENTER. Not later than 90 days after the date of enactment of this Act, the Director of National Drug Control Policy shall develop and submit to Congress a plan for the management of the Center which shall include a design and format for each of the data bases to be established by the Center. The plan shall utilize existing intelligence resources and shall not duplicate current information systems. SEC. 6. PARTICIPATING AGENCIES. The following agencies shall participate in the establishment of the strategic drug intelligence data bases and shall contribute data as required by the Board: (1) the Central Intelligence Agency; (2) the Defense Intelligence Agency; (3) the National Security Agency; (4) the Drug Enforcement Administration; (5) the Federal Bureau of Investigation; (6) the Internal Revenue Service; (7) the Immigration and Naturalization Service; (8) the Customs Service; and (9) the Coast Guard. SEC. 7. AVAILABILITY OF INFORMATION. The information in each data base established by the Center shall be available to appropriate representatives from participating agencies pursuant to the procedures adopted by the Board. SEC. 8. SECURITY OF CENTER. The Congress finds that given the nature of the Center's mission, the threat to the Center's facilities and its personnel is of special concern. In order to protect the Center's facilities and personnel, the Board shall take reasonable, necessary actions to provide the appropriate and necessary degree of physical and personnel security. SEC. 9. REPORTS AND EVALUATION. Not later than 1 year after the date of enactment of this Act and not later than March 1 of each year thereafter, the Director of National Drug Control Policy shall prepare and submit to Congress a report evaluating the performance of the Center and the participation of each of the contributors to the data bases of the Center. SEC. 10. AUTHORIZATION OF APPROPRIATIONS. For purposes of carrying out this Act, there are authorized to be appropriated $100,000,000 for fiscal year 1991 and such sums as may be necessary for each of the 3 succeeding fiscal years, which amounts shall remain available until expended.